313 related articles for article (PubMed ID: 23293895)
1. Safety and efficacy of intradermal injection of botulinum toxin for the treatment of oily skin.
Rose AE; Goldberg DJ
Dermatol Surg; 2013 Mar; 39(3 Pt 1):443-8. PubMed ID: 23293895
[TBL] [Abstract][Full Text] [Related]
2. Use of intradermal botulinum toxin to reduce sebum production and facial pore size.
Shah AR
J Drugs Dermatol; 2008 Sep; 7(9):847-50. PubMed ID: 19112798
[TBL] [Abstract][Full Text] [Related]
3. A Randomized, Double-Blinded Study Evaluating the Safety and Efficacy of AbobotulinumtoxinA Injections for Oily Skin of the Forehead: A Dose-Response Analysis.
Kesty K; Goldberg DJ
Dermatol Surg; 2021 Jan; 47(1):56-60. PubMed ID: 32769519
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and possible mechanisms of botulinum toxin treatment of oily skin.
Shuo L; Ting Y; KeLun W; Rui Z; Rui Z; Hang W
J Cosmet Dermatol; 2019 Apr; 18(2):451-457. PubMed ID: 30697928
[TBL] [Abstract][Full Text] [Related]
5. Sebum Production Alteration after Botulinum Toxin Type A Injections for the Treatment of Forehead Rhytides: A Prospective Randomized Double-Blind Dose-Comparative Clinical Investigation.
Min P; Xi W; Grassetti L; Trisliana Perdanasari A; Torresetti M; Feng S; Su W; Pu Z; Zhang Y; Han S; Zhang YX; Di Benedetto G; Lazzeri D
Aesthet Surg J; 2015 Jul; 35(5):600-10. PubMed ID: 25825422
[TBL] [Abstract][Full Text] [Related]
6. Treatment of forehead/glabellar rhytide complex with combination botulinum toxin a and hyaluronic acid versus botulinum toxin A injection alone: a split-face, rater-blinded, randomized control trial.
Dubina M; Tung R; Bolotin D; Mahoney AM; Tayebi B; Sato M; Mulinari-Brenner F; Jones T; West DP; Poon E; Nodzenski M; Alam M
J Cosmet Dermatol; 2013 Dec; 12(4):261-6. PubMed ID: 24305424
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
[TBL] [Abstract][Full Text] [Related]
8. Intradermal Botulinum Toxin A Injection for Scalp Sebum Secretion Regulation: A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Prospective Study in Chinese Subjects.
Li Y; Chen X; Luo X; Li L; Lin Y
Aesthet Surg J; 2023 Jan; 43(1):NP38-NP48. PubMed ID: 36004504
[TBL] [Abstract][Full Text] [Related]
9. Intradermal Microdroplet Injection of Diluted Incobotulinumtoxin-A for Sebum Control, Face Lifting, and Pore Size Improvement.
Park JY; Cho SI; Hur K; Lee DH
J Drugs Dermatol; 2021 Jan; 20(1):49-54. PubMed ID: 33400411
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Skin Physiology Change and Safety After Intradermal Injections With Botulinum Toxin: A Randomized, Double-Blind, Placebo-Controlled, Split-Face Pilot Study in Rosacea Patients With Facial Erythema.
Kim MJ; Kim JH; Cheon HI; Hur MS; Han SH; Lee YW; Choe YB; Ahn KJ
Dermatol Surg; 2019 Sep; 45(9):1155-1162. PubMed ID: 30730346
[TBL] [Abstract][Full Text] [Related]
11. Randomized controlled study of the efficacy of the injection of botulinum toxin type A versus corticosteroids in chronic plantar fasciitis: results at one and six months.
Díaz-Llopis IV; Rodríguez-Ruíz CM; Mulet-Perry S; Mondéjar-Gómez FJ; Climent-Barberá JM; Cholbi-Llobel F
Clin Rehabil; 2012 Jul; 26(7):594-606. PubMed ID: 22144721
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of intradermal injections of botulinum toxin in the management of enlarged facial pores and seborrhea: a split face-controlled study.
Sayed KS; Hegazy R; Gawdat HI; Abdel Hay RM; Ahmed MM; Mohammed FN; Allam R; Fahim A
J Dermatolog Treat; 2021 Nov; 32(7):771-777. PubMed ID: 31865815
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type a injection for lateral canthal rhytids : effect on tear film stability and tear production.
Ho MC; Hsu WC; Hsieh YT
JAMA Ophthalmol; 2014 Mar; 132(3):332-7. PubMed ID: 24385079
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of a novel botulinum toxin type A product for the treatment of moderate to severe glabellar lines: a randomized, double-blind, active-controlled multicenter study.
Won CH; Lee HM; Lee WS; Kang H; Kim BJ; Kim WS; Lee JH; Lee DH; Huh CH
Dermatol Surg; 2013 Jan; 39(1 Pt 2):171-8. PubMed ID: 23301821
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of the safety and efficacy of botulinum toxin type A and topical creams for treating moderate-to-severe glabellar rhytids.
Beer KR
Dermatol Surg; 2006 Feb; 32(2):184-97. PubMed ID: 16442037
[TBL] [Abstract][Full Text] [Related]
16. Are There Differences Between Intradermal and Intramuscular Injections of Botulinum Toxin on the Forehead?
Kim YJ; Lim OK; Choi WJ
Dermatol Surg; 2020 Dec; 46(12):e126-e131. PubMed ID: 32205751
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor.
Van Der Walt A; Sung S; Spelman T; Marriott M; Kolbe S; Mitchell P; Evans A; Butzkueven H
Neurology; 2012 Jul; 79(1):92-9. PubMed ID: 22753445
[TBL] [Abstract][Full Text] [Related]
18. A Single-blind, Split-face, Randomized, Pilot Study Comparing the Effects of Intradermal and Intramuscular Injection of Two Commercially Available Botulinum Toxin A Formulas to Reduce Signs of Facial Aging.
Sapra P; Demay S; Sapra S; Khanna J; Mraud K; Bonadonna J
J Clin Aesthet Dermatol; 2017 Feb; 10(2):34-44. PubMed ID: 28367260
[No Abstract] [Full Text] [Related]
19. Satisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystonia.
Sethi KD; Rodriguez R; Olayinka B
J Med Econ; 2012; 15(3):419-23. PubMed ID: 22208596
[TBL] [Abstract][Full Text] [Related]
20. Multiple intradermal small bolus injection of botulinum toxin: the limit and the potentiality.
Lee SK
J Cosmet Laser Ther; 2012 Dec; 14(6):304-6. PubMed ID: 23057657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
